FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282917152> ?p ?o ?g. }

• W4282917152 endingPage "697" @default.
• W4282917152 startingPage "693" @default.
• W4282917152 abstract "Prevention and treatment of type 2 diabetes and obesity are problematic for individuals with schizophrenia partly because atypical antipsychotics and mental distress themselves increase appetite, thus promoting subsequent body weight gain and deterioration of glycemic control. Glucagon-like peptide-1 (GLP-1) receptor agonists have been gaining attention for their glucose-lowering and body weight-reducing effects in obese individuals with type 2 diabetes generally, but their effects in those also having schizophrenia have not been adequately addressed.This case was a 50-year-old obese woman having type 2 diabetes and schizophrenia. Although she was receiving oral anti-diabetes treatment, her HbA1c remained inadequately controlled (8.0-9.0%) partly due her difficulty in following instructions on heathy diet and exercise. In addition, she was repeatedly hospitalized due to suicide attempts by overdosing on her anti-psychotic and anti-diabetes drugs. Her HbA1c was elevated to as high as 10.2% despite the use of multiple anti-diabetes drugs including the GLP-1 receptor agonist dulaglutide, and she was hospitalized in our department. We chose the GLP-1 receptor agonist semaglutide to replace dulaglutide along with a multidisciplinary team approach that included a cognitive-behavioral therapist. The patient perceived that her hunger was suppressed when she started receiving semaglutide 0.5 mg. After discharge, semaglutide was remarkably more effective than dulaglutide in that it reduced and maintained the patient's HbA1c and body weight for 6 months after initiation of the drug.The GLP-1 receptor agonist semaglutide can be effective in maintaining appropriate control of glycemia and body weight in diabetes and obesity with schizophrenia." @default.
• W4282917152 created "2022-06-16" @default.
• W4282917152 creator A5010930189 @default.
• W4282917152 creator A5021330407 @default.
• W4282917152 creator A5040020165 @default.
• W4282917152 creator A5041137849 @default.
• W4282917152 creator A5043929472 @default.
• W4282917152 creator A5047945748 @default.
• W4282917152 creator A5050839282 @default.
• W4282917152 creator A5053608620 @default.
• W4282917152 creator A5058218476 @default.
• W4282917152 creator A5061019344 @default.
• W4282917152 creator A5061627528 @default.
• W4282917152 creator A5061810022 @default.
• W4282917152 creator A5063515948 @default.
• W4282917152 creator A5081800565 @default.
• W4282917152 date "2022-06-15" @default.
• W4282917152 modified "2023-10-12" @default.
• W4282917152 title "Semaglutide is effective in type 2 diabetes and obesity with schizophrenia" @default.
• W4282917152 cites W2087523820 @default.
• W4282917152 cites W2154366324 @default.
• W4282917152 cites W2315740307 @default.
• W4282917152 cites W2417298918 @default.
• W4282917152 cites W2527926557 @default.
• W4282917152 cites W2621462012 @default.
• W4282917152 cites W2772389138 @default.
• W4282917152 cites W2787255324 @default.
• W4282917152 cites W2958543234 @default.
• W4282917152 cites W2960796216 @default.
• W4282917152 cites W2968073288 @default.
• W4282917152 cites W2970171902 @default.
• W4282917152 cites W3000421662 @default.
• W4282917152 cites W3013242926 @default.
• W4282917152 cites W3018053472 @default.
• W4282917152 cites W3127565158 @default.
• W4282917152 cites W4249844731 @default.
• W4282917152 doi "https://doi.org/10.1007/s13340-022-00590-1" @default.
• W4282917152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36117924" @default.
• W4282917152 hasPublicationYear "2022" @default.
• W4282917152 type Work @default.
• W4282917152 citedByCount "3" @default.
• W4282917152 countsByYear W42829171522023 @default.
• W4282917152 crossrefType "journal-article" @default.
• W4282917152 hasAuthorship W4282917152A5010930189 @default.
• W4282917152 hasAuthorship W4282917152A5021330407 @default.
• W4282917152 hasAuthorship W4282917152A5040020165 @default.
• W4282917152 hasAuthorship W4282917152A5041137849 @default.
• W4282917152 hasAuthorship W4282917152A5043929472 @default.
• W4282917152 hasAuthorship W4282917152A5047945748 @default.
• W4282917152 hasAuthorship W4282917152A5050839282 @default.
• W4282917152 hasAuthorship W4282917152A5053608620 @default.
• W4282917152 hasAuthorship W4282917152A5058218476 @default.
• W4282917152 hasAuthorship W4282917152A5061019344 @default.
• W4282917152 hasAuthorship W4282917152A5061627528 @default.
• W4282917152 hasAuthorship W4282917152A5061810022 @default.
• W4282917152 hasAuthorship W4282917152A5063515948 @default.
• W4282917152 hasAuthorship W4282917152A5081800565 @default.
• W4282917152 hasBestOaLocation W42829171522 @default.
• W4282917152 hasConcept C118552586 @default.
• W4282917152 hasConcept C126322002 @default.
• W4282917152 hasConcept C134018914 @default.
• W4282917152 hasConcept C147583825 @default.
• W4282917152 hasConcept C170493617 @default.
• W4282917152 hasConcept C185280430 @default.
• W4282917152 hasConcept C2776412080 @default.
• W4282917152 hasConcept C2777180221 @default.
• W4282917152 hasConcept C2777369949 @default.
• W4282917152 hasConcept C2778938600 @default.
• W4282917152 hasConcept C2779829264 @default.
• W4282917152 hasConcept C2780473172 @default.
• W4282917152 hasConcept C2780533449 @default.
• W4282917152 hasConcept C2781308992 @default.
• W4282917152 hasConcept C2909862629 @default.
• W4282917152 hasConcept C511355011 @default.
• W4282917152 hasConcept C544821477 @default.
• W4282917152 hasConcept C555293320 @default.
• W4282917152 hasConcept C71924100 @default.
• W4282917152 hasConceptScore W4282917152C118552586 @default.
• W4282917152 hasConceptScore W4282917152C126322002 @default.
• W4282917152 hasConceptScore W4282917152C134018914 @default.
• W4282917152 hasConceptScore W4282917152C147583825 @default.
• W4282917152 hasConceptScore W4282917152C170493617 @default.
• W4282917152 hasConceptScore W4282917152C185280430 @default.
• W4282917152 hasConceptScore W4282917152C2776412080 @default.
• W4282917152 hasConceptScore W4282917152C2777180221 @default.
• W4282917152 hasConceptScore W4282917152C2777369949 @default.
• W4282917152 hasConceptScore W4282917152C2778938600 @default.
• W4282917152 hasConceptScore W4282917152C2779829264 @default.
• W4282917152 hasConceptScore W4282917152C2780473172 @default.
• W4282917152 hasConceptScore W4282917152C2780533449 @default.
• W4282917152 hasConceptScore W4282917152C2781308992 @default.
• W4282917152 hasConceptScore W4282917152C2909862629 @default.
• W4282917152 hasConceptScore W4282917152C511355011 @default.
• W4282917152 hasConceptScore W4282917152C544821477 @default.
• W4282917152 hasConceptScore W4282917152C555293320 @default.
• W4282917152 hasConceptScore W4282917152C71924100 @default.
• W4282917152 hasFunder F4320334764 @default.
• W4282917152 hasIssue "4" @default.

• next